Differential redistribution of activated monocyte and dendritic cell subsets to the lung associates with severity of COVID-19

I Sanchez-Cerrillo, P Landete, B Aldave… - MedRxiv, 2020 - medrxiv.org
The SARS-CoV-2 is responsible for the pandemic COVID-19 in infected individuals, who
can either exhibit mild symptoms or progress towards a life-threatening acute respiratory …

Monocytes and macrophages, targets of severe acute respiratory syndrome coronavirus 2: the clue for coronavirus disease 2019 immunoparalysis

A Boumaza, L Gay, S Mezouar, E Bestion… - The Journal of …, 2021 - academic.oup.com
Abstract Background Coronavirus disease 2019 (COVID-19) clinical expression is
pleiomorphic, severity is related to age and comorbidities such as diabetes and …

Immunomodulation: a broad perspective for patients' survival of COVID-19 infection

CF Adeboboye, BO Oladejo… - European Journal of …, 2020 - journals.tmkarpinski.com
The pathogenesis of the SARS-CoV-2 virus is yet to be well understood. However, patients
with the virus show clinical manifestations which are very similar to those of SARS-CoV and …

Multi-organ involvement in COVID-19: beyond pulmonary manifestations

V Thakur, RK Ratho, P Kumar, SK Bhatia, I Bora… - Journal of clinical …, 2021 - mdpi.com
Coronavirus Disease 19 (COVID-19), due to severe acute respiratory syndrome coronavirus-
2 (SARS-CoV-2) has become an on-going global health emergency affecting over 94 million …

Interleukin-6, CXCL10 and infiltrating macrophages in COVID-19-related cytokine storm: not one for all but all for one!

F Coperchini, L Chiovato, M Rotondi - Frontiers in immunology, 2021 - frontiersin.org
SARS-COV-2 virus is responsible for the ongoing devastating pandemic. Since the early
phase of the pandemic, the “cytokine-storm” appeared a peculiar aspect of SARS-COV-2 …

[HTML][HTML] The chemokine MIG is associated with an increased risk of COVID-19 mortality in mexican patients

RLA Ochoa, PR Ramos, GGR Jimenez, MJ Rodriguez… - 2022 - sid.ir
Background: Coronavirus disease 2019 (COVID-19) is an emergent viral disease in which
the host inflammatory response modulates the clinical outcome. Severe outcomes are …

Targeting cytokine storm as the potential anti-viral therapy: Implications in regulating SARS-CoV-2 pathogenicity

S Maity, A Santra, AV Hebbani, S Pulakuntla… - Gene, 2023 - Elsevier
The latest global pandemic corona virus disease-2019 (COVID-19) caused by the virus
SARS-CoV-2 is still a matter of worrying concern both for the scientific communities and …

Dynamic changes in circulatory cytokines and chemokines levels in mild to severe COVID-19 patients

V Tiwari, J Agarwal, AK Pathak, S Singh - Indian Journal of Clinical …, 2023 - Springer
Immune dysregulation is a key feature of the coronavirus disease-2019 (COVID-19).
However, disparities in responses across ethnic groups are underappreciated. This study …

[PDF][PDF] Higher plasma levels of Chemokine CCL19 are associated with poor SARS-CoV-2 acute respiratory distress syndrome (ARDS) outcomes

J Balnis, AP Adam, A Chopra, HC Chieng, PJ Feustel… - MedRxiv, 2020 - medrxiv.org
COVID19 pandemic has so far caused over three hundred thousand deaths worldwide,
primarily due to complications from SARS-CoV-2-associated acute respiratory distress …

[HTML][HTML] Metabolic modeling of single bronchoalveolar macrophages reveals regulators of hyperinflammation in COVID-19

Q Zhao, Z Yu, S Zhang, XR Shen, H Yang, Y Xu, Y Liu… - Iscience, 2022 - cell.com
SARS-CoV-2 infection induces imbalanced immune response such as hyperinflammation in
patients with severe COVID-19. Here, we studied the immunometabolic regulatory …